Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-025645
Filing Date
2020-09-17
Accepted
2020-09-17 21:50:34
Documents
2
Period of Report
2020-09-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3978
2 EX-24 DOCUMENT attachment1.htm EX-24 4755
  Complete submission text file 0000899243-20-025645.txt   10225
Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL ST., SUITE 101 WATERTOWN MA 02472
Business Address
Chodakewitz Jeffrey (Reporting) CIK: 0001610876 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38359 | Film No.: 201182673

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations